insights_auto
Why is MTRI down 7.10%?
Dive Deeperchevron_right
MTRI:NASDAQ
Mentari Therapeutics, Inc.
$14.20
arrow_downward
-7.10%(-1.08) 1D
Nov 19, 3:20:06 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MTRI...
Open
$14.90
High
$15.51
Low
$13.81
Mkt. cap
749.71M
Avg. vol.
24.25K
Volume
15.62K
52-wk high
$20.00
52-wk low
$12.20
EPS
-$29.15
Beta
0.94
Shares outstanding
52.81M
No. of employees
6
Open
$14.90
High
$15.51
Low
$13.81
Mkt. cap
749.71M
Avg. vol.
24.25K
Volume
15.62K
52-wk high
$20.00
52-wk low
$12.20
EPS
-$29.15
Beta
0.94
Shares outstanding
52.81M
No. of employees
6
News stories
From web sources and news partners
ChartMill
·
42 minutes ago
S&P 500 Top Movers: Gainers and Losers Today
TradingView
·
3 hours ago
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
Investing.com
·
4 hours ago
Record-negative dealer gamma and what it means for the S&P 500
Traders Union
·
33 minutes ago
Caleb Franzen: S&P 500 performance and AI stocks diverged under Powell and Warsh
About Mentari Therapeutics, Inc.
CEOEric A. Adams
Employees6
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteinmedpharma.com